AstraZeneca | Page 8 | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Tales from the Edge
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Saturday
August 01, 2026

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Tales from the Edge
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Explainer
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SATURDAY, AUGUST 01, 2026

AstraZeneca

AstraZeneca

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

US puts J&J in charge of plant that botched Covid vaccine, removes AstraZeneca

AstraZeneca, whose vaccine has not been approved in the United States, said it will work with President Joe Biden’s administration to find an alternative site to produce its vaccine

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

7 deaths in UK among AstraZeneca jab recipients after blood clots

The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels as part of the coronavirus disease (COVID-19) vaccination campaign, Belgium, January 28, 2021. REUTERS/Johanna Geron

Dutch temporarily halt AstraZeneca shots for under-60s

Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo

Australia to continue AstraZeneca vaccination despite blood clotting case

A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration/File Photo

EU pledges to keep AstraZeneca doses in the bloc for now

A vail of the Oxford-AstraZeneca Covid-19 vaccine is seen at Basingstoke Fire Station, in Basingstoke, Britain February 4, 2021. REUTERS/Peter Cziborra/File Photo

AstraZeneca confirms strong vaccine protection after US rift

Vials labelled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe are seen in front of a displayed AstraZeneca logo, in this illustration photo taken March 14, 2021. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo

Asia accelerates AstraZeneca Covid-19 vaccine rollouts, even as trust plunges in Europe

FILE PHOTO: A test tube labelled with the Vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

10 UK warns EU vaccine export ban would be ‘counter-productive’

The vaccine allegedly "stimulates broad antibody and T cell functions Photo: Medical Xpress

Poll points to AstraZeneca concerns as Europe protests grow

The vaccine allegedly "stimulates broad antibody and T cell functions Photo: Medical Xpress

South Africa sells AstraZeneca Covid-19 vaccines to other African Union member nations

FILE PHOTO: Indonesian soldiers sit as one of them receives a dose of China's Sinovac Biotech vaccine for the coronavirus disease (COVID-19), during a mass vaccination program at a sport hall in Jakarta, Indonesia, March 10, 2021. REUTERS/Ajeng Dinar Ulfiana

AstraZeneca counters Indonesian Muslim concerns over Covid-19 vaccine

A pedestrian crosses a road, as streets have again become empty in Milan, Italy, amid precautions against coronavirus second wave. Photo :Collected

Fresh lockdowns in Europe as EU threatens AstraZeneca export ban

A healthcare worker shows a vial and a box of the AstraZeneca coronavirus disease (COVID-19) vaccine, as vaccinations resume after a brief pause in their use over concern for possible connection to blood clots, in Turin, Italy, March 19, 2021. REUTERS/Massimo Pinca

Scientists probe new theories on whether AstraZeneca shot linked to blood clots

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2026
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net